Patent ID: 11857564
Assignee: OMRIX BIOPHARMACEUTICALS LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. A hemostatic composition comprising:
Diethylaminoethyl (DEAE) bound to a matrix; and a calcium salt;
wherein:
(i) a polyanionic polymer is not present in the hemostatic composition;
(ii) thrombin is not present in the hemostatic composition;
(iii) the calcium is present at a concentration of from 1 to 100 mM or the ratio between the matrix and the calcium salt in the composition ranges from 1:5 to 1:70, respectively, by weight;
(iv) the hemostatic composition comprises a homogenous blend of said matrix and calcium, and wherein:
(v) wherein the hemostatic composition is a blend in the form selected from powder, slurry and liquid.